Skip to main content

Wearable device startup Encora Therapeutics brings in $1.5M pre-seed round

Encora is working on building affordable, non-invasive neurostimulation devices for those affected by movement disorders, including Parkinson's. The wearables work by sensing, then counteracting a patient’s motor symptoms via customized vibratory stimulation to the wrist.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.